For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

The European Medicines Agency plays a central role in the regulation of Europe’s medicines supply. The Coronavirus pandemic has led the EU to expand and strengthen the EMA’s powers in pharmaceutical policy. This is happening against the backdrop of globalization, where the EMA is both influenced by and impacting on pharmaceutical policy far beyond its borders. This seminar unpacks and discusses these issues from the perspective of law and governance.

Event details of The European Medicines Agency: An emerging player in global health policy
Date 13 December 2021
Time 15:30 -17:00
Organised by Katrina Perehudoff


Dr. Katrina Perehudoff, Senior Research Fellow, Law Centre for Health and Life, University of Amsterdam

Dr. Sabrina Röttger-Wirtz, Assistant Professor of EU Law, Faculty of Law, Maastricht University

Mr. Martin Harvey Allchurch LLM, Head of International Affairs, European Medicines Agency

Ms. Ancella Santos Quintano MSc, Senior Health Policy Officer, The European Consumers Organisation

Dr Elena Petelos, Vice President HTA, EUPHA and Co-Chair RWE & AI, HTAi

Moderated by Ms. Pramiti Parwani LLM, Law Centre for Health and Life, University of Amsterdam

Organised by Law Centre for Health and Life, the Amsterdam Centre for European Law and Governance, the Amsterdam Institute for Global Health and Development, and the EUPHA Law & Public Health section.